Guggenheim Capital’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.16M Buy
37,211
+2,710
+8% +$147K 0.02% 678
2025
Q4
$1.59M Sell
34,501
-934
-3% -$41.8K 0.01% 748
2025
Q3
$1.28M Sell
35,435
-107
-0.3% -$3.54K 0.01% 835
2025
Q2
$1.16M Buy
35,542
+7,536
+27% +$247K 0.01% 833
2025
Q1
$1.06M Buy
28,006
+1,556
+6% +$124K 0.01% 859
2024
Q4
$2.17M Sell
26,450
-3,350
-11% -$333K 0.02% 625
2024
Q3
$3.41M Sell
29,800
-224
-0.7% -$20.2K 0.02% 650
2024
Q2
$2.27M Sell
30,024
-1,448
-5% -$98.6K 0.02% 772
2024
Q1
$2.15M Buy
31,472
+3,915
+14% +$271K 0.02% 857
2023
Q4
$1.73M Sell
27,557
-2,729
-9% -$142K 0.01% 903
2023
Q3
$1.54M Buy
30,286
+1,225
+4% +$60.4K 0.01% 909
2023
Q2
$1.45M Buy
29,061
+4,672
+19% +$221K 0.01% 992
2023
Q1
$914K Buy
+24,389
New +$1.03M 0.01% 1227

Other funds holding PCVX